Company intelligence / Profile preview

Valsynthese

Gamsen, Valais, Switzerland

Ownership: Private
Development stage: Commercial

Overview

Valsynthese provides custom synthesis and contract manufacturing services for the chemical and pharmaceutical industries. They specialize in high-energy and hazardous chemistry under cGMP/ISO standards. Their facilities produce advanced intermediates, fine chemicals, APIs with DMF registration, and animal health products. They do not have their own clinical pipeline but support client programs from process development through commercial production.

Modalities: Small moleculeAdvanced intermediates (for APIs)Active pharmaceutical ingredients (APIs)Fine chemicals synthesisAnimal health products
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

betaine citrate

Commercial

Indications: Digestive disorders

Partnerships

Chemium srl (Belgium): Collaboration on Grignard reagents production using MgFlow® technology.

Beyond the preview

Go deeper on Valsynthese.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valsynthese.

Explore the full profile